Methyl 6-[3-[3,5-bis(trifluoromethyl)phenyl]-3-methylpyrrolidin-1-yl]-4-(trifluoromethyl)pyridine-3-carboxylate
C21H17F9N2O2 — CID 88585389
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 6-[3-[3,5-bis(trifluoromethyl)phenyl]-3-methylpyrrolidin-1-yl]-4-(trifluoromethyl)pyridine-3-carboxylate
Methyl 6-[3-[3,5-bis(trifluoromethyl)phenyl]-3-methylpyrrolidin-1-yl]-4-(trifluoromethyl)pyridine-3-carboxylate (PubChem CID 88585389) has the molecular formula C21H17F9N2O2 and a molecular weight of 500.36 g/mol. Its IUPAC name is methyl 6-[3-[3,5-bis(trifluoromethyl)phenyl]-3-methylpyrrolidin-1-yl]-4-(trifluoromethyl)pyridine-3-carboxylate.
Molecular Properties
| Compound Name | Methyl 6-[3-[3,5-bis(trifluoromethyl)phenyl]-3-methylpyrrolidin-1-yl]-4-(trifluoromethyl)pyridine-3-carboxylate |
|---|---|
| PubChem CID | 88585389 |
| Molecular Formula | C21H17F9N2O2 |
| Molecular Weight | 500.36 g/mol |
| Exact Mass | 500.11 |
| IUPAC Name | methyl 6-[3-[3,5-bis(trifluoromethyl)phenyl]-3-methylpyrrolidin-1-yl]-4-(trifluoromethyl)pyridine-3-carboxylate |
| SMILES | COC(=O)c1cnc(N2CCC(C)(c3cc(C(F)(F)F)cc(C(F)(F)F)c3)C2)cc1C(F)(F)F |
| InChI | InChI=1S/C21H17F9N2O2/c1-18(11-5-12(19(22,23)24)7-13(6-11)20(25,26)27)3-4-32(10-18)16-8-15(21(28,29)30)14(9-31-16)17(33)34-2/h5-9H,3-4,10H2,1-2H3 |
| InChIKey | FGRITQHSRJTFDS-UHFFFAOYSA-N |
| XLogP | 6.09 |
| TPSA | 42.43 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 500.36 |
| LogP ≤ 5 | 6.09 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 88585389 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.